sweetboy6622
عضو نشط
WebAlert: Advanced Cell to Hold Conference Call Today at 12 Noon ET to Discuss Technique to Produce Stem Cells without Harming Embryo
Friday August 25, 6:30 am ET
Company to Review Milestones and Mission to Develop and Commercialize Groundbreaking Stem Cell Technology
ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 25, 2006--Advanced Cell Technology, Inc. (OTCBB:ACTC - News), developers of groundbreaking human embryonic stem cell technologies to create next-generation medical therapies, will host a live investor conference call with a simultaneous webcast, today at 12 noon Eastern, to discuss its novel technique to generate human embryonic stem cell lines while preserving the original embryo's potential for life and development.
Advanced Cell Chief Executive Officer, William Caldwell IV and Dr. Michael D. West, Ph.D., President and Chief Scientific Officer of ACT, will discuss the company's scientific advances and business initiatives, and will address investor questions.
To participate, please register online as explained below. The webcast will last approximately 30 minutes.
WHAT: Conference Call with Advanced Cell Technology
WHEN: Today, August 25, 2006, at 12 noon Eastern
HOW: Callers within the United States may dial (800) 230-1074.
When prompted, tell the operator that you would like to
connect to the Advanced Cell conference call. International
callers can dial 612-332-0228.
COST: The conference call is free of charge.
WEBCAST: An online audio simulcast of the call will also be
accessible at
http://www.trilogy-capital.com/tcp/advanced_cell/.
About Advanced Cell Technology, Inc.
Advanced Cell Technology Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Contact:
Financial Dynamics
Robert Stanislaro, 212-850-5657 (Media)
or
The Investor Relations Group
James Carbonara, 212-825-3210 (Investors)
or
Financial Communications
Trilogy Capital Partners
Paul Karon, 800-592-6067
paul@trilogy-capital.com
--------------------------------------------------------------------------------
Source: Advanced Cell Technology, Inc.
Friday August 25, 6:30 am ET
Company to Review Milestones and Mission to Develop and Commercialize Groundbreaking Stem Cell Technology
ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 25, 2006--Advanced Cell Technology, Inc. (OTCBB:ACTC - News), developers of groundbreaking human embryonic stem cell technologies to create next-generation medical therapies, will host a live investor conference call with a simultaneous webcast, today at 12 noon Eastern, to discuss its novel technique to generate human embryonic stem cell lines while preserving the original embryo's potential for life and development.
Advanced Cell Chief Executive Officer, William Caldwell IV and Dr. Michael D. West, Ph.D., President and Chief Scientific Officer of ACT, will discuss the company's scientific advances and business initiatives, and will address investor questions.
To participate, please register online as explained below. The webcast will last approximately 30 minutes.
WHAT: Conference Call with Advanced Cell Technology
WHEN: Today, August 25, 2006, at 12 noon Eastern
HOW: Callers within the United States may dial (800) 230-1074.
When prompted, tell the operator that you would like to
connect to the Advanced Cell conference call. International
callers can dial 612-332-0228.
COST: The conference call is free of charge.
WEBCAST: An online audio simulcast of the call will also be
accessible at
http://www.trilogy-capital.com/tcp/advanced_cell/.
About Advanced Cell Technology, Inc.
Advanced Cell Technology Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Contact:
Financial Dynamics
Robert Stanislaro, 212-850-5657 (Media)
or
The Investor Relations Group
James Carbonara, 212-825-3210 (Investors)
or
Financial Communications
Trilogy Capital Partners
Paul Karon, 800-592-6067
paul@trilogy-capital.com
--------------------------------------------------------------------------------
Source: Advanced Cell Technology, Inc.
